Early Insights From Clinical Trials of Typhoid Conjugate Vaccine
Open Access
- 29 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (Supplement) , S155-S159
Abstract
Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.Keywords
This publication has 20 references indexed in Scilit:
- Case Fatality Rate of Enteric Fever in Endemic Countries: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2018
- Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trialThe Lancet, 2017
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- The burden of typhoid fever in low- and middle-income countries: A meta-regression approachPLOS Neglected Tropical Diseases, 2017
- Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 StudyClinical Infectious Diseases, 2015
- Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustmentThe Lancet Global Health, 2014
- The role of public health improvements in health advances: The twentieth-century United StatesDemography, 2005
- The global burden of typhoid fever.2004
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicityBMJ, 1998